This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why iRobot (IRBT) Might be Well Poised for a Surge
by Zacks Equity Research
iRobot (IRBT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
iRobot (IRBT) Shares Gain 65% YTD: What's Driving the Rally?
by Zacks Equity Research
iRobot (IRBT), with 65% growth in shares so far in 2020, benefits from impressive financial performance and solid demand for its Roomba and Braava products. However, the pandemic-related woes are concerning.
iRobot (IRBT) in Focus: Stock Moves 9.6% Higher
by Zacks Equity Research
iRobot (IRBT) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
iRobot (IRBT) Hikes Q2 Sales and Operating View, Stock Rises
by Zacks Equity Research
iRobot (IRBT) hikes sales projections for Q2, primarily driven by healthy orders for Roomba and Braava products. Also, it reiterates that the second half of 2020 will be better than the first half.
Stocks to Gap Lower on Second Wave Fears
by Jeremy Mullin
Aggressive selling overnight has the bears in control.
iRobot (IRBT) Up 21.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
iRobot (IRBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Healthcare Tech & Robotics ETFs in Focus amid COVID-19 Crisis
by Neena Mishra
The pandemic will forever transform our lives; here are some areas that may benefit.
Macquarie (MIC) Earnings and Revenues Miss Estimates in Q1
by Zacks Equity Research
Macquarie's (MIC) first-quarter 2020 revenues decrease 14% year over year on account of lackluster performance across its segments.
Cimpress (CMPR) Q3 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Cimpress' (CMPR) third-quarter fiscal 2020 revenues decrease y/y on account of lackluster performance across most of its segments.
A. O. Smith (AOS) Earnings and Sales Miss Estimates in Q1
by Zacks Equity Research
A. O. Smith's (AOS) first-quarter 2020 net sales decrease about 15% year over year on account of lackluster performance across the Rest of World segment.
iRobot (IRBT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
iRobot's (IRBT) first-quarter 2020 earnings suffer from the impacts of the coronavirus outbreak. Sales challenges are likely to persist in the near term, while cost-savings and other actions to aid.
IRobot (IRBT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
iRobot (IRBT) delivered earnings and revenue surprises of 4.48% and 6.96%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Industrial Stocks' Apr 28 Earnings Roster: CAT, ROP & More
by Zacks Equity Research
A peak at how Caterpillar (CAT), Roper Technologies (ROP), Rockwell Automation (ROK) and other industrials are expected to fare this earnings season amid the coronavirus impact.
How are Industrial Product Stocks Placed for Q1 Earnings?
by Payal Jalan
The coronavirus outbreak mars earnings and revenue prospects for many companies under the Industrial Products sector. Collective results for the first quarter of 2020 might be lackluster.
Diverse Companies Join Forces to Fight Coronavirus Menace
by Payal Jalan
Nervousness related to the coronavirus outbreak is visible across the economies worldwide. Amid the pandemic, many corporates have come together to help contain the outbreak.
4 Reasons Why You Should Avoid iRobot (IRBT) Stock for Now
by Zacks Equity Research
iRobot's (IRBT) operations are exposed to the adverse impacts of the coronavirus outbreak as well as tariff-related woes and stiff competition. It withdraws projections for 2020.
iRobot (IRBT) Withdraws Annual View on Coronavirus Concerns
by Zacks Equity Research
Due to the pandemic, iRobot (IRBT) lowers sales view for first-quarter 2020 and withdraws annual projections. It expects to witness relief if Roomba products get excluded from Section 301 tariffs.
Why Is iRobot (IRBT) Down 16.9% Since Last Earnings Report?
by Zacks Equity Research
iRobot (IRBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Implied Volatility Surging for iRobot (IRBT) Stock Options
by Zacks Equity Research
Investors need to pay close attention to iRobot (IRBT) stock based on the movements in the options market lately.
iRobot (IRBT) Q4 Earnings Surpass Estimates, Q1 View Bleak
by Zacks Equity Research
iRobot's (IRBT) Q4 earnings exceed estimates while the same deteriorates year over year on weak margins. It predicts Q1 results to soften from the adverse impacts of tariffs, pricing and promotional actions.
IRobot (IRBT) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
iRobot (IRBT) delivered earnings and revenue surprises of 66.67% and 3.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Will Promotion Costs, Tariffs Ail iRobot (IRBT) Q4 Earnings?
by Zacks Equity Research
iRobot's (IRBT) Q4 results are likely to reflect adverse impacts of high promotional costs, increased tariffs and reduced prices of products. However, growth in U.S. and international sales might aid.
Earnings Preview: iRobot (IRBT) Q4 Earnings Expected to Decline
by Zacks Equity Research
IRobot (IRBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inphi, iRobot, Netflix, Disney and Apple highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Inphi, iRobot, Netflix, Disney and Apple highlighted as Zacks Bull and Bear of the Day
Bear of the Day: iRobot (IRBT)
by Benjamin Rains
iRobot shares have tumbled 40% in the last six months. The drop came after the robotic vacuum maker narrowed its earnings and revenue outlook as the U.S.-China trade war takes its toll...